愛國者運輸控股控股 PATI 深 滬
等待開盤 10-22 09:30:00 美东时间
16.26
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 16.26
- 總市值 5734.09万
- 52周最高 16.26
- 市盈率 靜 21.86
- 換手率 0.00%
- 52周最低 6.95
- 委 比 0.00%
- 總股本 352.65万
- 歷史最高 29.94
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.32
- 每 手 1
- 風險率 3.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多喜讯 | 君逸数码控股子公司海天数联全系列AI产品获华为鲲鹏技术认证
近日，君逸数码控股子公司海天数联自主研发的全系列AI产品线——AI智能体平台、AI视频分析平台、低代码机器学习平台、知识图谱平台，顺利完成华为Kunpeng ...
10-09 11:17
Patria Announces Third Quarter 2025 Investor Call
Patria, a global alternative asset management firm, will release its third-quarter 2025 financial results on November 4, 2025, and host a conference call at 9:00 a.m. ET. Registration and details are available on their website. A webcast replay will be accessible post-broadcast. Investors can also sign up for email alerts for press releases and updates. Patria, with $48 billion in AUM, specializes in resilient sectors across Latin America, Europe...
10-08 20:30
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
Eligible Patients Can Access Repatha at Nearly 60% Discount From the List Price THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of AmgenN...
10-06 21:00
Kolte-Patil Developers Secures ‘CARE AA-‘ Rating for Rs. 250 Crore NCD Issue
Kolte-Patil Developers Limited ( ($IN:KOLTEPATIL) ) has shared an announcement....
10-05 08:55
AbivaxTo Present Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology
Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) MeetingLate Breaking Abstract titled EFFICACY OF OBEFAZIMOD
09-24 04:09
Kolte-Patil Developers Re-Appoints Cost Auditor for FY 2025-26
Kolte-Patil Developers Limited ( ($IN:KOLTEPATIL) ) just unveiled an update. Ko...
09-23 01:05
荣联知识库管理和智能应答平台获华为鲲鹏双项技术认证
近日，荣联科技集团自主研发的知识库管理与智能应答平台与华为鲲鹏完成双重技术认证，正式获得“KUNPENG COMPATIBLE”与“KUNPENG NATIV...
09-01 10:58
艾融软件企业现金管理软件获华为鲲鹏双认证，信创能力再进阶
2025 年 8 月 1 日，上海艾融软件股份有限公司的企业现金管理软件成功通过华为技术有限公司 Kunpeng 920 V200...
08-04 17:17
佳缘科技AI电子病历质控系统成功通过华为昇腾&鲲鹏双技术认证
【华为认证】全文621字，阅读约需2分钟 近日，凭借领先的技术架构、卓越的性能表现以及对华为鲲鹏、昇腾基础软硬件平台的深度适配，佳缘科技自主研发的核心产品“A...
07-24 18:00
IMDELLTRA® SIGNIFICANTLY REDUCED RISK OF DEATH BY 40% IN SMALL CELL LUNG CANCER PATIENTS
Breakthrough Second-Line Treatment Demonstrated Survival Advantage over Standard-of-Care Chemotherapy Late-Breaking Data Presented at ASCO 2025 and Simultaneously Published in The New Engla...
06-02 20:04
